Trimethoprim-Sulfamethoxazole Treatment for Severe Pertussis in Infants Younger Than 2 months During a Macrolide-Resistant Bordetella pertussis Outbreak: A Case Series

Since 2023, macrolide-resistant Bordetella pertussis (MRBP) has surged worldwide. Six infants aged